لا تُقدم XM خدماتها لمواطني الولايات المتحدة الأمريكية.
M
M

McKesson


أخبار

Mckesson Says Ontada Collaborates With Microsoft To Transform Unstructured Oncology Data With Azure OpenAI Technology

BRIEF-Mckesson Says Ontada Collaborates With Microsoft To Transform Unstructured Oncology Data With Azure OpenAI Technology Oct 17 (Reuters) - Mckesson Corp MCK.N : MCKESSON: ONTADA COLLABORATES WITH MICROSOFT TO TRANSFORM UNSTRUCTURED ONCOLOGY DATA WITH AZURE OPENAI TECHNOLOGY Further company coverage: MCK.N
M
M

U.S. Costco Wholesale, McKesson, Starbucks

CORRECTED-U.S. RESEARCH ROUNDUP-Costco Wholesale, McKesson, Starbucks Corrects named item code to RCH/US from RCH/EUROPE, the same error was there in a previous version of the U.S. research roundup Sept 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Costco Wholesale, McKesson and Starbucks, on Tuesday.
C
R
S
M
C
L

Costco Wholesale, McKesson, Starbucks

CORRECTED-US RESEARCH ROUNDUP-Costco Wholesale, McKesson, Starbucks Corrects named item code to RCH/US from RCH/EUROPE; a previous version was corrected to fix headline tag to US RESEARCH ROUNDUP from EUROPE RESEARCH ROUNDUP and to change media packaging code to RESEARCH-US/ Sept 24 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Costco Wholesale, McKesson and Starbucks on Tuesday.
C
S
M
C
L

Cardinal Health to acquire Integrated Oncology Network for $1.12 billion

UPDATE 2-Cardinal Health to acquire Integrated Oncology Network for $1.12 billion Adds details and background throughout Sept 20 (Reuters) - Cardinal Health CAH.N on Friday agreed to acquire community cancer center operator Integrated Oncology Network for $1.12 billion in cash, marking its expansion into cancer care. The Dublin, Ohio-based company is the latest to join the trend of healthcare service companies diversifying beyond drug distribution.
M

Baltimore to take drug distributors to trial over opioids

UPDATE 1-Baltimore to take drug distributors to trial over opioids Adds comment from Cencora in paragraph 4 By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.
T
W
M

Baltimore to take drug distributors to trial over opioids

CORRECTED-Baltimore to take drug distributors to trial over opioids Corrects headline and lead, adds paragraphs 4-5 to state that J&J settled before trial By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.
T
W
M

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

UPDATE 1-Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial Adds comment from J&J in paragraph 6 By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.
T
W
M

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.
T
W
M

U.S. STOCKS JPMorgan, automakers, energy firms

BUZZ-U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday ahead of key inflation data later this week that could provide clarity on the extent of the Federal Reserve's expected interest rate cut, while a fall in the shares of big banks weighed on the markets.
A
B
C
J
S
W
U
U
M

U.S. STOCKS Arrowhead Pharma, Boeing, Centessa Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq rose on Tuesday as most megacap stocks gained, with focus now moving to key inflation data later this week that could provide more clarity on the extent of the Federal Reserve's expected interest rate cut on Sept.
A
B
C
G
J
S
W
U
U
M

Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal

BUZZ-Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal ** Brokerage Jefferies cuts PT on drug distributor McKesson MCK.N to $607 from $630, while raising PT on peer Cardinal Health CAH.N to $110 from $105 ** Says despite MCK forecasting Q2 below estimates, co's reiteration of full-year forecast gives "some level of confidence" *
W
M

Column: Opioid plaintiffs' committee urges US appeals court to toss fee bid by shut-out law firms

Column: Opioid plaintiffs' committee urges US appeals court to toss fee bid by shut-out law firms The opinions expressed here are those of the author, a columnist for Reuters. By Alison Frankel Sept 9 (Reuters) - When it comes to calling dibs on $2.1 billion set aside for lawyers who contributed to settlements with nine major opioids defendants, the plaintiffs' lawyers in charge of the sweeping nationwide case are not kidding around.
T
M

U.S. Broadcom, Costco Wholesale, Saia

U.S. RESEARCH ROUNDUP-Broadcom, Costco Wholesale, Saia Sept 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Broadcom, Costco Wholesale and Saia on Friday. HIGHLIGHTS * Broadcom Inc AVGO.O : JP Morgan raises target price to $210 from $200 * Costco Wholesale Corp COST.O : Oppenheimer raises target price to $955 from $925 * Globant SA GLOB.N : JP Morgan raises target price to $237 from $226 * Saia Inc SAIA.O : JP Morg
A
B
C
C
E
D
M
Z
C
F
I
R

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Dollar Tree Inc DLTR.OQ +6.8% Marketaxess Holdings Inc MKTX.OQ +6.5% Tesla Inc TSLA.OQ +4.4% Hormel Foods Corp HRL.N +3.0% Comcast Corp CMCSA.OQ +2.7% Bottom Performers Percent Change Mckesson Corp MCK.N -11.1% Zimmer Biomet Holdings I
C
T
D
U
M
Z
C
M
O

U.S. STOCKS MarketAxess, Perpetua Resources, Sotera Health

BUZZ-U.S. STOCKS ON THE MOVE-MarketAxess, Perpetua Resources, Sotera Health Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's three main indexes slipped in choppy trading on Thursday as a short-lived boost from a services activity survey fizzled out ahead of an upcoming employment report.
J
N
N
T
V
U
D
U
U
M
S
Z
F

Drug distributor McKesson forecasts Q2 profit below estimates

UPDATE 1-Drug distributor McKesson forecasts Q2 profit below estimates Adds shares in paragraph 1, details and background throughout Sept 5 (Reuters) - Drug distributor McKesson MCK.N on Thursday forecast second-quarter profit below Wall Street estimates, sending its shares down 9%. The company said in a filing it expects adjusted profit for the second quarter to be between $6.70 and $7 per share, below analysts' average estimate of $7.39, according to LSEG data.
M

McKesson falls after forecasting Q2 profit below estimates

BUZZ-McKesson falls after forecasting Q2 profit below estimates ** Shares of drug distributor McKesson Corp MCK.N fall 9% to $519.89 ** Co sees Q2 adjusted profit per share in the range of $6.70 to $7.00 vs estimates of $7.39 -LSEG ** Reaffirms fiscal 2025 adjusted per-share profit to be between $31.75 and $32.55 ** Stock down ~13% YTD Reporting by
M

Drug distributor McKesson forecasts Q2 profit below estimates

Drug distributor McKesson forecasts Q2 profit below estimates Sept 5 (Reuters) - Drug distributor McKesson MCK.N on Thursday forecast second-quarter profit below Wall Street estimates. The company expects adjusted profit for the second quarter to be between $6.70 and $7 per share, compared with analysts' average estimate of $7.39, according to LSEG data.
M

U.S. STOCKS Modular Medical, Beazer Homes, oil firms

BUZZ-U.S. STOCKS ON THE MOVE-Modular Medical, Beazer Homes, oil firms Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 inched up on Thursday after a services activity survey allayed some fears of a slowdown in economic activity, while focus continues to be on the Federal Reserve's interest rate cut that is expected later this month.
J
N
T
V
U
U
U
U
M
S
Z
F

Mckesson Corp Reaffirms Fiscal 2025 Adjusted EPS Guidance

BRIEF-Mckesson Corp Reaffirms Fiscal 2025 Adjusted EPS Guidance Sept 5 (Reuters) - Mckesson Corp MCK.N : AFFIRMED FISCAL 2025 ADJUSTED EPS GUIDANCE IN RANGE OF $31.75 TO $32.55 : SEES Q2 FISCAL 2025 ADJUSTED EARNINGS PER DILUTED SHARE TO BE IN RANGE OF $6.70 TO $7.00 FY2025 EARNINGS PER SHARE VIEW $32.21 -- LSEG IBES DATA Q2 EARNINGS PER SHARE VIEW
M



الشروط

الأصول الشائعة

إخلاء المسؤولية: تتيح كيانات XM Group خدمة تنفيذية فقط والدخول إلى منصة تداولنا عبر الإنترنت، مما يسمح للشخص بمشاهدة و/أو استخدام المحتوى المتاح على موقع الويب أو عن طريقه، وهذا المحتوى لا يراد به التغيير أو التوسع عن ذلك. يخضع هذا الدخول والاستخدام دائماً لما يلي: (1) الشروط والأحكام؛ (2) تحذيرات المخاطر؛ (3) إخلاء المسؤولية الكامل. لذلك يُقدم هذا المحتوى على أنه ليس أكثر من معلومات عامة. تحديداً، يرجى الانتباه إلى أن المحتوى المتاح على منصة تداولنا عبر الإنترنت ليس طلباً أو عرضاً لدخول أي معاملات في الأسواق المالية. التداول في أي سوق مالي به مخاطرة عالية برأس مالك.

جميع المواد المنشورة على منصة تداولنا مخصصة للأغراض التعليمية/المعلوماتية فقط ولا تحتوي - ولا ينبغي اعتبار أنها تحتوي - على نصائح أو توصيات مالية أو ضريبية أو تجارية، أو سجلاً لأسعار تداولنا، أو عرضاً أو طلباً لأي معاملة في أي صكوك مالية أو عروض ترويجية مالية لا داعي لها.

أي محتوى تابع للغير بالإضافة إلى المحتوى الذي أعدته XM، مثل الآراء، والأخبار، والأبحاث، والتحليلات والأسعار وغيرها من المعلومات أو روابط مواقع تابعة للغير وواردة في هذا الموقع تُقدم لك "كما هي"، كتعليق عام على السوق ولا تعتبر نصيحة استثمارية. يجب ألا يُفسر أي محتوى على أنه بحث استثماري، وأن تلاحظ وتقبل أن المحتوى غير مُعدٍ وفقاً للمتطلبات القانونية المصممة لتعزيز استقلالية البحث الاستثماري، وبالتالي، فهو بمثابة تواصل تسويقي بموجب القوانين واللوائح ذات الصلة. فضلاً تأكد من أنك قد قرأت وفهمت الإخطار بالبحوث الاستثمارية غير المستقلة والتحذير من مخاطر المعلومات السابقة، والذي يمكنك الاطلاع عليه هنا.

تحذير المخاطر: رأس مالك في خطر. المنتجات التي تستخدم الرافعة قد لا تكون مناسبة للجميع. يرجى الاطلاع على تنبيه المخاطر.